INTRODUCTION
============

Obesity is an excessive accumulation of body fat and its gross manifestation poses a real threat to health and the prevalence in children has increased dramatically over the last 20--30 years in developed countries. It is a health risk frequently associated with complications such as type 2 diabetes, dyslipidemia, high blood pressure, abnormal fibrinolysis, and cardiovascular disease \[[@B1], [@B2], [@B3]\].

Leptin, the product of the *ob* gene, is a recently discovered proteohormone that is thought to play a key role in the regulation of body weight \[[@B4]\]. It is produced by the adipocytes to regulate food intake at a hypothalamic level, and its circulating levels directly correlate with the amount of body fat and body mass index (BMI). It is accepted that serum leptin levels reflect the extent of adiposity \[[@B5], [@B6]\]. Leptin concentration is increased in most obese adults and children, indicating that such simple obese subjects are irresponsive to the lipostatic action of leptin \[[@B7], [@B8]\]. Also leptin-deficient and leptin-receptor-deficient mice show an obese phenotype \[[@B9]\].

A number of proinflammatory cytokines, such as interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-*α*, and interferon (IFN)-*γ* have been proposed as mediators of the cachectic process \[[@B10]\]. Moreover, evidence has been provided that *ob* gene expression may be up regulated by proinflammatory cytokines such as IL-1 and TNF-*α*, producing prompt, dose-dependent increases in serum leptin concentrations. Although it has recently been shown that TNF-*α* administration increases leptin expression and circulating concentrations in rodents, the activation of the TNF-*α* system may exert a significant influence over leptin levels in humans \[[@B11]\]. Production of acute-phase proteins is under control of macrophage-derivated cytokines, for example, IL-1*β*, TNF-*α*, and IL-6. These substances mediate not only inflammatory and immune reactions, but also the development of cachexia \[[@B12]\].

On the other hand, in children, higher inflammation levels in overweight and obese children predispose to disease at older age as myocardial infarction, peripheral arterial disease, ischemic stroke, and diabetes mellitus. However, in adults many factors correlated with obesity can cause higher inflammation levels including smoking, arthritis, and cardiovascular disease. But, association between obesity and inflammation in prepubertal children supports a direct relationship because the prevalence of smoking, atherosclerosis, and preexisting disease is low \[[@B13]\].

Further elucidation of the potential interaction between these two systems could provide important insights into the feedback system for regulation of body weight and the mechanisms leading to obesity and cachexia in humans. So far, it has not yet been shown in prepubertal children how cytokines, leptin, and body mass, as well as parameters of obesity are interrelated. The aim of this study was to explore the relation between circulating levels of some cytokines with leptin and body mass index.

SUBJECTS AND METHODS
====================

Study design
------------

A case control study was carried out in obese children of both sexes. A child was considered obese when their body weight exceeded 120% of the standard body weight, which is defined as the mean body weight corresponding to the height for that age from national statistics for Turkish school children and when body mass index was over the 99th percentile in the growth curve for the study population \[[@B14]\], because this is the only limit that allows for the selection of markedly obese children.

An obese group was composed of 63 school prepubertal children and a control group comprised the same number of nonobese children paired by age and by sex. All subjects were at Tanner stage 1. Children with primary hyperlipidemia, hypertension, diabetes or glucose intolerance, and secondary obesity and who received pharmacological agents were excluded. The study was approved by The Local Ethical Committee, and informed consent was given by parents.

Blood samples was drawn from children constituting obese and control groups, which was authorized by parents, at the visit of their school in the morning after overnight fast; at the same time, they were subjected to anthropometric measurements including height and weight. The serum was separated and kept frozen at −24^°^C until analysis.

Analytical measurements
-----------------------

Body weight and body height were obtained from each subject by nurses using electrical scales and wall-mounted stadiometer. Body mass index was calculated as weight in kilograms divided by height in m^2^ and used as an index of nutritional status.

The tests from collected samples were carried out in the laboratory of the Department of Biochemistry. Serum leptin levels were determined with an enzyme-linked immunosorbent assay (ELISA) method using commercial kits (Leptin kit, DRG International, Inc, NJ) and the sensitivity of detection level was 7.2 pg/mL. Serum concentrations of cytokines such as IL-1*β*, IL-2, IL-6, and TNF-*α* were measured using commercially available ELISA kits (ELISA, Pharmingen Inc, San Diego, Calif) and the sensitivity of detection for IL-1*β*, IL-2, IL-6, and TNF-*α* was 3.5 pg/mL, 0.02 U/L, 2.1 pg/mL, and 1.8 pg/mL, respectively. All of the serum samples were analyzed in duplicate with a range less than 10%.

Statistical analysis
--------------------

Values are expressed as mean ± SD. All calculation was made with the statistical program SPSS version 10.0 on an IBM compatible computer. All the main study variables were positively skewed and therefore transformed and used.

In order to compare the obese and the control group with respect to leptin, cytokines, height SDS, and BMI SDS, one-way analysis of variance (ANOVA) and Tukey B and Scheffe (post-ANOVA) tests were used and a *P* value \< .05 was considered significant.

The relationships between the data of the study and the control groups were investigated by Pearson\'s correlation.

RESULTS
=======

The characteristics of obese and control group children are listed in [Table 1](#T1){ref-type="table"}. The two groups did not differ significantly in age, gender, and height. The mean BMI was 24.0 ± 4.0 kg/m^2^ in the obese group and was 17.5 ± 2.3 kg/m^2^ in the control group; the difference was statistically significant (*P* \< .001).

Serum cytokines and leptin values in the two groups are listed in [Table 2](#T2){ref-type="table"}. Mean plasma leptin concentration was significantly higher in the obese children at 19.9 ± 7.4 ng/mL in comparison to the control children at 7.9 ± 5.1 ng/mL (*P* \< .001). Serum leptin concentrations were in correlation with BMI in obese children (*r* = 0.651, *P* \< .001). Serum IL-1*β*, IL-6, and TNF-*α* levels were also significantly higher in the obese group than the control group (33.0 ± 8.9, 45.2 ± 11.8, and 9.2 ± 2.3 pg/mL, versus 3.6 ± 1.0, 13.1 ± 3.9, and 3.9 ± 1.0 pg/mL, resp; *P* \< .001). In a controversy, serum IL-2 level was significantly lower in the obese prepubertal children than the control group (0.4 ± 0.1 versus 0.9 ± 0.1 U/L).

In obese children, serum leptin levels were positively correlated with serum IL-1*β*, IL-6, and TNF-*α* levels (*r* = 0.563, *P* \< .01, *r* = 0.377, and *r* = 0.418, *P* \< .05, resp) and inversly correlated with serum IL-2 (*r* = −0.471, *P* \< .01) level. There was no correlation between cytokines level of obese children, simply between IL-6 and TNF-*α* (*r* = 0.395, *P* \< .05).

DISCUSSION
==========

The etiology of obesity represents a complex interaction of genetics, diet, metabolism, and physical activity levels. Leptin levels correlate with adiposity, decrease actually with caloric restriction, and increase with refeeding. The brain is an established critical site of leptin function \[[@B15]\].

In the larger Chard longitudinal study of leptin levels and body composition in normal children, it was observed that leptin levels rose gradually with age in both boys and girls until the onset of puberty. However there was a wide variation in leptin levels at the onset of puberty, so the level of this threshold may differ greatly between individuals \[[@B16]\].

Serum leptin levels were found by Kırel et al \[[@B17]\] higher to be in obese children than in those normal weighted. Also strongly correlated with BMI are skinfold thickness and body weight as described previously in adults and adolescents. It was hypothesized that leptin is delivered to the brain by a saturable transport system. A decreased capacity to transport leptin to the brain via cerebrospinal fluid has already been shown in obese humans despite having higher leptin concentrations than those found in lean individuals. This is another mechanism that may provide an explanation for leptin resistance in obese children \[[@B18]\]. In our study, also serum leptin levels were revealed to be higher in obese prepubertal children than in the control group and were well correlated with BMI.

On the other hand obesity has been associated with higher inflammation levels in adults. However, many factors correlated with obesity can cause higher inflammation levels, including smoking, arthritis, cardiovascular disease, and diabetes mellitus. The recent findings of an association between obesity and inflammation in prepubertal children support a direct relationship because the prevalence of smoking, atherosclerosis, and preexisting disease is low in children \[[@B13]\].

In this study, serum IL-1*β* and serum TNF-*α* levels were detected to be higher in prepubertal obese children than healthy normal-weighted subjects. However, serum IL-2 and IL-6 levels were higher in healthy subjects. These serum cytokines levels were well correlated with serum leptin levels and BMI. In a study on children with diabetes mellitus type 1, the authors showed that the serum concentration of IL-1*β*, IL-2, IL-6, and TNF-*α* was significantly correlated with leptin which was determined by the excess of adiposity \[[@B19]\].

TNF-*α* is a proinflammatory cytokine that involves the production of other cytokines, such as IL-1 and IL-6. Several cytokines, such as IL-1*α*, IL-6, and TNF-*α*, by increasing hypothalamic CRH gene expression, may activate the same CRH pathway as the leptin-catabolic effector system. Considering that leptin receptor is a member of the class I cytokine receptor family and that leptin activates intracellular signal transduction pathways common in many cytokines, the proinflammatory ones act as leptin-like factors and mimic the effectors leptin, decreasing energy intake and increasing energy expenditure \[[@B20]\]. The same cytokines raise leptin in rodents \[[@B11]\]. Santos-Alvares et al \[[@B21]\] found that leptin stimulating the proliferation of human circulating monocytes increases the production of IL-6, and to a lesser extent TNF-*α* supporting a hypothetic role of leptin as a new proinflammatory cytokine. Loffreda et al \[[@B22]\] showed that leptin enhances the synthesis of proinflammatory cytokines by cultured macrophages.

The relationship of the TNF-*α* system to energy and metabolic homeostasis is potentially complex. On the one hand, increased levels of TNF-*α* have been associated with weight loss, hypermetabolism, and increased resting energy expenditure as measured by indirect calorimetry in several disease stocks, and administration of TNF-*α* is capable of producing some of these effects \[[@B23]\]. On the other hand, increased TNF-*α* expression in adipose cells is seen in obesity and has been linked to the development of insulin resistance \[[@B22]\]. First activation of the TNF-*α* system has been associated with increased energy expenditure and weight loss in humans. The association between serum leptin and TNF-*α*-R 55 levels raises the intriguing possibility that the TNF-*α* system may act through the leptin system to increase energy expenditure and thereby induce weight loss in humans \[[@B23]\]. Second, it is well recognized that neuroendocrine function is subject to regulation by the immune system in humans, and it has recently been shown that leptin is a potent mediator of the neuroendocrine response in mice \[[@B11]\]. Thus, these data raise the possibility that one or more effects of the immune system on neuroendocrine function could, in addition to direct effects by cytokines on the central nervous system, be mediated through changes of the leptin system \[[@B21]\].

Cytokine secretion within adipocytes appears similar to that of other cells. There is general agreement that circulating TNF-*α* and IL-6 concentrations are mildly elevated in obesity. Most studies suggest that increased TNF-*α* mRNA expression or secretion in vitro in adipose tissue appears to include usual inflammatory stimuli such as lipopolysaccaride, the size of the fat cells per se, and catecholamine. The effects of cytokines within adipose tissue include some actions that might be characterized as metabolic. TNF-*α* and IL-6 inhibit lipoprotein lipase and TNF-*α* additionally stimulates hormone-sensitive lipase and induces uncoupling protein expression \[[@B24]\].

Children and adolescents with obesity accompanied by hypertension and diabetes have elevated levels of IL-6 and TNF-*α*. IL-6 and TNF-*α* correlates with body mass index not only in obese but also in hypertensive, slim children. The elevated levels of cytokines (IL-6, TNF-*α*) in children with atherosclerosis risk factors (particularly obesity) can confirm the presence of inflammatory process in early phases of atherosclerosis \[[@B25]\].

Leptin, by enhancing IL-1 concentrations, may pose proinflammatory actions, whereas neurotransmitters such as serotonin, dopamine, and neuropeptide *Y* show anti-inflammatory actions by inducing acetylcholine release, which in turn suppresses the production of proinflammatory cytokines \[[@B26]\].

In conclusion, obesity may be a low-grade systemic inflammatory disease. Obese prepubertal children have elevated serum levels of IL-1*β*, IL-6, TNF-*α*, and leptin which are known as markers of inflammation. These results may contribute to the increased risk of diabetes and heart diseases in obese children.

###### 

Characteristics of subjects.

  --------------- ------------- ------------- ---------
  Variables       Obese         Control       *P*
  *n* = 63        *n* = 63                    
                                              
  Age (years)     8.8 ± 1.2     8.9 ± 1.0     NS
  Gender (M/F)    26/37         26/37         ---
  Weight (kg)     45.2 ± 2.8    3.19 ± 1.4    \< .001
  Height (cm)     137.2 ± 1.4   134.9 ± 1.0   NS
  BMI (kg/m^2^)   24.0 ± 4.0    17.5 ± 2.3    \< .001
  --------------- ------------- ------------- ---------

###### 

Serum cytokines and leptin concentrations.

  ----------------- ------------- ------------ ---------
  Variables         Obese         Control      *P*
  *n* = 63          *n* = 63                   
                                               
  Leptin (ng/mL)    19.9 ± 7.4    7.9 ± 5.1    \< .001
  IL-1*β*(pg/mL)    33.0 ± 8.9    3.6 ± 1.0    \< .001
  IL-2(U/L)         0.4 ± 0.1     0.9 ± 0.1    \< .01
  IL-6 (pg/mL)      45.2 ± 11.8   13.1 ± 3.9   \< .001
  TNF-*α* (pg/mL)   9.2 ± 2.3     3.9 ± 1.0    \< .001
  ----------------- ------------- ------------ ---------
